| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | 32.0× | −1.7× | |
| Price / Book | 6.8× | 2.0× | |
| Price / Sales | 10.5× | 3.9× | |
| Price / Free cash flow | 39.7× | −1.6× | |
| EV / EBITDA | 25.8× | −1.2× | |
| Earnings yield | 3.1% | −14.6% | |
| Free cash flow yield | 2.5% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,247.73 | −0.74% | $1.17T | 57.3× | 77.8% | +16.7% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $253.91 | −0.65% | $611.9B | 23.0× | 32.9% | +33.7% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $283.79 | −0.57% | $501.49B | 119.3× | −129.2% | +26.2% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $406.63 | +1.30% | $364.99B | 29.9× | 12.8% | +11.2% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $143.96 | −1.36% | $355.17B | 19.7× | 34.7% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $150.28 | −0.23% | $278B | 19.8× | 30.5% | +15.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $164.13 | −0.77% | $254.55B | 25.0× | 21.1% | −2.2% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $679.40 | −1.54% | $251.21B | 37.9× | 12.6% | +30.7% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $425.65 | −1.58% | $230.12B | 30.3× | 89.1% | +45.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $153.32 | −1.84% | $190.1B | 22.8× | 37.5% | +32.0% |
